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Phenotype
Sample Size (N)
Number of SNPs Total (NSS)
Central nervous system (CNS) disorders Phenotypes: psychiatric and other neurological diseases (Alzheimer's disease (AD), attentiondeficit/hyperactivity disorder (ADHD), bipolar disorder (BD), major depressive disorder (MDD), migraine, multiple sclerosis (MS), first and second edition of the schizophrenia GWAS by the Psychiatric Genomic Consortium (SCZ1 and SCZ2)), anthropometric measures (body mass index (BMI), height, waist-hip ratio (WHR)), cardiovascular risk factors (systolic blood pressure (SBP), total cholesterol (TC), triglycerides (TG)), immune-mediated diseases (Crohn's disease (CD), celiac disease (CeD), rheumatoid arthritis (RA), ulcerative colitis (UC)). psychiatric and other neurological diseases (Alzheimer's disease (AD), attentiondeficit/hyperactivity disorder (ADHD), bipolar disorder (BD), major depressive disorder (MDD), migraine, multiple sclerosis (MS), first and second edition of the schizophrenia GWAS by the Psychiatric Genomic Consortium (SCZ1 and SCZ2)), anthropometric measures (body mass index (BMI), height, waist-hip ratio (WHR)), cardiovascular risk factors (systolic blood pressure (SBP), total cholesterol (TC), triglycerides (TG)), immune-mediated diseases (Crohn's disease (CD), celiac disease (CeD), rheumatoid arthritis (RA), ulcerative colitis (UC)). . This track consists of two entries per SNP, which the authors call (z score + variance) and (z score -variance). Since a negative NSS-score is expected to indicate a possible positive selection in humans, the (z-score + variance) entries are conservative measures of positive selection likelihood. These were extracted for all SNPs in the genome-wide association studies of interest (Table S1 ) and follow the distribution illustrated here. (Fig. 1) . The non-divergent (ND) SNPs also show unchanged deflection from the baseline (B; All SNPs). This suggests that there is no relevant overlap among MHC SNPs and the SCZ susceptibility SNPs in human divergent regions. (Fig. 2) , there is no indication of enrichment the likes of that seen for schizophrenia in (Fig. 1). (B) The fold enrichment counterparts of the Q-Q plots in (A) emphasize the association enrichment. ADHD in particular does present some deflection but the number of SNPs involved is too exiguous to result in any significant association as measured by the regression analysis (Table S2) . (Fig. 2) , there is no indication of enrichment the likes of that seen for schizophrenia in (Fig. 1). (B) The fold enrichment counterparts of the Q-Q plots in (A) emphasize the association enrichment or rather the lack thereof. (Fig. 1) but is confirmed by a nominally significant association between squared z-scores and Neanderthal selective sweep scores ( Table 1) . S8 . Effect size comparison. Squared z-scores logarithm Neanderthal selective sweep score regression coefficients (mean ± SE) for phenotypes: psychiatric and other neurological diseases (Alzheimer's disease (AD), attention-deficit/hyperactivity disorder (ADHD), bipolar disorder (BD), major depressive disorder (MDD), migraine, multiple sclerosis (MS), first and second edition of the schizophrenia GWAS by the Psychiatric Genomic Consortium (SCZ1 and SCZ2)), body mass index (BMI), height, waist-hip ratio (WHR), systolic blood pressure (SBP), total cholesterol (TC), triglycerides (TG), Crohn's disease (CD), celiac disease (CeD), rheumatoid arthritis (RA), ulcerative colitis (UC). For sample sizes in the respective genome-wide association studies, see Table S1 . Reported are (A) quantile-quantile (Q-Q) and (B) fold enrichment plots of autosome and X chromosome GWAS summary statistics p-values for schizophrenia, stratified based on Neanderthal selective sweep score. The enrichment of the human divergent (HD) category, represented by its deflection from the diagonal (A), is still clear and we do not see comparable differences from the analysis devoid of the X chromosome (Fig. 1) . The non-divergent (ND) SNPs also show unchanged deflection from the baseline (All SNPs).
Supplemental Methods & Materials
Confounding Factors
Possible confounding factors that might influence the results are addressed in the analyses: the effect size computed in the regression analysis typical of most SNP association studies depends on the SNP's frequency f through its genotypic variance 2f (1-f) . A SNP's frequency or its genotypic variance can therefore constitute confounders if other factors, e.g. the covariates, used in the enrichment analysis are correlated with them. It is possible that SNPs that underwent positive selection after divergence from Neanderthal have unusual frequency distributions. All analyses are therefore carried out while controlling for genotypic variance.
The chromosomal linkage disequilibrium (LD) structure is another feature that undergoes differential amounts of transformations depending on the type of selection pressure and is therefore controlled for in the analyses as well.
Major Histocompatibility Complex (MHC)
The MHC has been implicated in schizophrenia as well as a number of other phenotypes, particularly immune-mediated diseases. The evolution of MHC itself may have involved segmental duplication and other large scale genetic variations (28) . It is therefore reasonable to suspect that SNPs in these regions might be driving some of the enrichment results. By removing the MHC region (chromosome 6 region between genomic positions 25652429 and 33421466 in the hg19 assembly) from the analyses, we aim at identifying their contribution to the enrichment patterns.
Replication
The z-scores of each of the 52 original sub-studies contributing to the schizophrenia metaanalysis (8) were independently adjusted using intergenic inflation control: the inflation factor, λ GC , was estimated as the median squared z-score across intergenic SNPs divided by the expected median of a chi-square distribution with one degree of freedom. The 52 sub-studies were then subdivided into two groups of 26 in 50 different ways, the first group, D k , k = 1…100, serving as discovery group, the second, R k , k = 1…100, as replication group. Average discovery and replication z-scores were computed for all SNPs and all 50 subdivisions 
Conditional False Discovery Rate (condFDR)
The observed enrichment can be directly interpreted in terms of the Bayesian FDR (29) .
Specifically, for a given p-value cutoff, the FDR is defined as 
Censored Analysis
Many of the 108 schizophrenia GWAS hits lie within or around genes that are involved in the biochemistry of neural cells. The genome regions that have undergone a selective sweep according to the NSS score have also been shown to contain genes involved with brain functions. 
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